The End Drug Shortages Alliance has released a market analysis of products affected by the recent shuttering of a Teva pharmaceutical manufacturing plant in Irvine, California, urging increased supply chain transparency to nip any resulting shortages in the bud. The closure is expected to impact 25 pharmaceutical injectables previously manufactured at the plant.
End Drug Shortages Alliance vice chair Terri Wilson said: “We are surfacing the information and amplifying it so that all...




